FDA Approves FoundationOne CDx to Identify EGFR Therapeutics for Certain Patients With NSCLC
FoundationOne CDx has been approved as a companion diagnostic to identify patients with non–small cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) exon 19 deletions or exon 21 alternations eligible for treatment with EGFR tyrosine kinase inhibitors.
What We’re Reading: FFS Medicare Savings; ICU Triage Discrimination; Pfizer, Moderna Patent Lawsuits
Medicare Advantage plan members could save $12 billion if enrolled in fee-for-service (FFS) plans instead; Black patients were classified as low priority for intensive care unit (ICU) triage twice as often as other patients; Moderna and Pfizer face lawsuits over potential COVID-19 vaccine patent infringement.
What We’re Reading: Paying to Quit Substance Use; Census Undercounts; Global COVID-19 Toll
A new opinion indicates paying those with substance use disorder to stay clean could be legal; the 2020 Census undercounted some racial minorities; the true global COVID-19 death toll could be 3 times higher than the official tally.
BMI, Waist Circumference Linked to Lung Function Decline in Pre- and Postmenopausal Women
Previous research has shown the health effects of obesity, including the decline in lung function. New research highlights obesity is a risk factor for asthma and chronic obstructive pulmonary disease in premenopausal and postmenopausal women.